James Still

1.4k total citations
27 papers, 927 citations indexed

About

James Still is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, James Still has authored 27 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Epidemiology. Recurrent topics in James Still's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Diabetes Management and Research (5 papers) and Diabetes Treatment and Management (4 papers). James Still is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Diabetes Management and Research (5 papers) and Diabetes Treatment and Management (4 papers). James Still collaborates with scholars based in United States, Australia and United Kingdom. James Still's co-authors include Frank C. Greiss, Gordana Kosutic, Stephen G. Anderson, Stephen Clement, Prabhavathi Fernandes, Paresh Dandona, Kay Clark, R. G. McAllister, Thorsten P. Degenhardt and Devjit Tripathy and has published in prestigious journals such as Diabetes Care, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

James Still

26 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Still United States 19 184 183 157 147 143 27 927
I. S. Menzies United Kingdom 18 288 1.6× 211 1.2× 25 0.2× 395 2.7× 88 0.6× 33 1.5k
J.C. Rambaud France 20 178 1.0× 413 2.3× 59 0.4× 470 3.2× 31 0.2× 38 1.7k
Tatsuhiko Azegami Japan 17 99 0.5× 340 1.9× 53 0.3× 59 0.4× 54 0.4× 62 850
L.A. Turnberg United Kingdom 17 134 0.7× 228 1.2× 26 0.2× 510 3.5× 22 0.2× 33 1.3k
Eva Prieschl‐Grassauer Austria 17 116 0.6× 206 1.1× 52 0.3× 73 0.5× 11 0.1× 26 1.1k
Armorel van Eyk South Africa 16 89 0.5× 102 0.6× 279 1.8× 32 0.2× 32 0.2× 50 733
James E. Rogers United States 11 39 0.2× 127 0.7× 19 0.1× 124 0.8× 65 0.5× 18 664
Christoph R. Werner Germany 12 341 1.9× 98 0.5× 41 0.3× 88 0.6× 12 0.1× 46 994
F. Guillot France 15 237 1.3× 220 1.2× 20 0.1× 70 0.5× 15 0.1× 28 886
Ton Naber Netherlands 20 186 1.0× 276 1.5× 10 0.1× 287 2.0× 67 0.5× 38 1.4k

Countries citing papers authored by James Still

Since Specialization
Citations

This map shows the geographic impact of James Still's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Still with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Still more than expected).

Fields of papers citing papers by James Still

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Still. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Still. The network helps show where James Still may publish in the future.

Co-authorship network of co-authors of James Still

This figure shows the co-authorship network connecting the top 25 collaborators of James Still. A scholar is included among the top collaborators of James Still based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Still. James Still is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrett, D, Sanela Bilic, Yung Chyung, et al.. (2021). A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy. Advances in Therapy. 38(6). 3203–3222. 30 indexed citations
2.
Still, James, Kristina E N Clark, Thorsten P. Degenhardt, et al.. (2011). Pharmacokinetics and Safety of Single, Multiple, and Loading Doses of Fusidic Acid in Healthy Subjects. Clinical Infectious Diseases. 52(Supplement 7). S504–S512. 19 indexed citations
3.
Craft, J. Carl, Kay Clark, Thorsten P. Degenhardt, et al.. (2011). A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections. Clinical Infectious Diseases. 52(suppl_7). S520–S526. 39 indexed citations
4.
Still, James. (2008). Single Oral Dose Pharmacokinetics and Safety of CEM-101 in Healthy Subjects. 46th Annual Meeting. 2 indexed citations
5.
Moore, Mary Courtney, Margaret Lautz, Melanie Scott, et al.. (2005). Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia. American Journal of Physiology-Endocrinology and Metabolism. 289(1). E46–E52. 7 indexed citations
6.
Chin, Christine, María J. Gutiérrez, James Still, & Gordana Kosutic. (2004). Pharmacokinetics of Modified Oral Calcitonin Product in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(8). 994–1001. 10 indexed citations
7.
Clement, Stephen, Paresh Dandona, James Still, & Gordana Kosutic. (2003). Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial. Metabolism. 53(1). 54–58. 55 indexed citations
8.
Kipnes, Mark, Paresh Dandona, Devjit Tripathy, James Still, & Gordana Kosutic. (2003). Control of Postprandial Plasma Glucose by an Oral Insulin Product (HIM2) in Patients With Type 2 Diabetes. Diabetes Care. 26(2). 421–426. 66 indexed citations
9.
Still, James. (2002). Development of oral insulin: progress and current status. Diabetes/Metabolism Research and Reviews. 18(S1). S29–S37. 89 indexed citations
10.
Clement, Stephen, James Still, Gordana Kosutic, & R. G. McAllister. (2002). Oral Insulin Product Hexyl-Insulin Monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: The Glucose Stabilization Effects of HIM2. Diabetes Technology & Therapeutics. 4(4). 459–466. 66 indexed citations
11.
Still, James. (2000). The Pediatric Research Initiative in the United States: Implications for Global Pediatric Research. Drug Information Journal. 34(1). 207–212. 2 indexed citations
12.
Gruber, William C., Paul M. Darden, James Still, et al.. (1997). Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Vaccine. 15(12-13). 1379–1384. 38 indexed citations
13.
Astiz, Mark E., Eric C. Rackow, James Still, et al.. (1995). Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin. Critical Care Medicine. 23(1). 9–17. 104 indexed citations
14.
Still, James. (1995). Management of pediatric patients with group A beta-hemolytic Streptococcus pharyngitis. The Pediatric Infectious Disease Journal. 14(4). S57–61. 49 indexed citations
15.
Still, James. (1995). REPLY. The Pediatric Infectious Disease Journal. 14(5). 403–403. 1 indexed citations
16.
Rheuban, Karen S., Nancy A. Ayres, James Still, & Bennett A. Alford. (1982). Pulmonary Artery Sling: A New Diagnostic Tool and Clinical Review. PEDIATRICS. 69(4). 472–475. 28 indexed citations
17.
Greiss, Frank C., James Still, & Stephen G. Anderson. (1976). Effects of local anesthetic agents on the uterine vasculatures and myometrium. American Journal of Obstetrics and Gynecology. 124(8). 889–899. 40 indexed citations
18.
Greiss, Frank C., Stephen G. Anderson, & James Still. (1976). Uterine pressure-flow relationships during early gestation. American Journal of Obstetrics and Gynecology. 126(7). 799–808. 23 indexed citations
19.
Still, James & Frank C. Greiss. (1976). Effect of Cis- and Trans-Clomiphene on the Uterine Blood Flow of Oophorectomized Ewes. Gynecologic and Obstetric Investigation. 7(4). 187–200. 9 indexed citations
20.
Still, James. (1973). Lamp. Appalachian heritage. 1(1). 45–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. S. Menzies Breakdown of academic impact, for papers by J.C. Rambaud Breakdown of academic impact, for papers by Tatsuhiko Azegami Breakdown of academic impact, for papers by L.A. Turnberg Breakdown of academic impact, for papers by Eva Prieschl‐Grassauer Breakdown of academic impact, for papers by Armorel van Eyk Breakdown of academic impact, for papers by James E. Rogers Breakdown of academic impact, for papers by Christoph R. Werner Breakdown of academic impact, for papers by F. Guillot Breakdown of academic impact, for papers by Ton Naber
Rankless by CCL
2026